Our news

• NovaMedica team participates in the Russian Pharmaceutical Forum in St. Petersburg

  14 May 2024

  

  31^st Russian Pharmaceutical Forum named after N.A. Semashko was launched in St. Petersburg today, May 14. Heads of pharmaceutical companies, government agencies and specialized associations are here to discuss the most pressing issues of the industry, give their assessments and forecasts, and propose ways to tackle challenges such as drug price regulation, elimination of shortages, development of API production in Russia, necessary government support measures, entering markets of friendly countries, etc. NovaMedica is represented at the forum by its CEO and member of the Board of Directors Elena LITVINOVA and the Head of the company’s Business Unit Oksana KRASNYKH.

• NovaMedica experts spoke to participants of GxP-Fest 2024 about career opportunities in the pharmaceutical industry

  27 April 2024

  

  On April 19, 2024, the final of the 4^th International Student Festival GxP-Fest 2024 took place at the Krasny Oktyabr space in Moscow. This was one of the main events organized by the Eurasian Academy of Good Practices with the support of the Ministry of Industry and Trade of the Russian Federation and the Eurasian Economic Commission for students and professors of specialized Russian and EAEU universities, representatives of Russian and foreign regulators and pharmaceutical companies, as well as experts in the field of professional education.

• Whales in the treatment of insomnia – Professor Yakupov’s speech at the “Bekhterev Readings – 2024” in Kazan

  14 March 2024

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  On March 13 in Kazan, at the 10^th Anniversary All-Russian Scientific and Practical Conference with International Participation “Bekhterev Readings – 2024”, a symposium was held under the auspices of the Russian Society of Somnologists: “Modern approaches to the diagnosis and treatment of sleep disorders”. It was at this discussion that Professor Eduard YAKUPOV, one of the most renowned neurologists and organizer of the Bekhterev Readings, gave such an original imaginative comparison of the NovaMedica drug with the most powerful inhabitants of the ocean – whales.

• Meeting point: Vein Readings. NovaMedica in active communication with neurologists at the legendary conference

  26 February 2024

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  NovaMedica actively endorsed and participated in the 20^th Anniversary Interdisciplinary Conference with International Participation “Vein Readings”, dedicated to current issues in neurology. The conference took place on February 19-21, 2024, in Moscow. NovaMedica provided support to several interesting events held to discuss modern methods of treating migraines, headaches and sleep disorders.

• NovaMedica team wishes you a Merry Christmas and a Happy New Year!

  26 December 2023

  

  NovaMedica team wishes you a Merry Christmas and a Happy New Year! The days leading up to these magical holidays always bring us excitement and joy. This is when we say our dearest wishes, since it is at this time that we believe in miracles with all our hearts. So, make your boldest wishes and may they all come true in the new year! Let 2024 be different: sometimes lively and cheerful, sometimes calm and dreamy, but always creative and successful. We hope that it will have space for new achievements and that it delights you every minute and fills your life with warmth. May your loved ones and your family always be with you, and may your home be full of friends, love and smiles.

• Grand finale from a veritable stalwart of neuroscience

  09 November 2023

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  A real gem of the Manage Pain Congress was the Grand Finale performed by Eduard YAKUPOV, Doctor of Medical Sciences, Professor, Head of the Professor Yakupov Neuroclinic and Education Center, which was held with the support of NovaMedica.

• Battle of pharma advocates – in search of the ideal migraine therapy

  09 November 2023

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  An exciting discussion on the treatment of migraine and headaches in the format of a competition between advocates took place at the 14^th Manage Pain Congress as part of the panel discussion “The ideal choice of treatment for a migraine attack. Triptans or NSAIDs*. Pro & Contra”, which was held with the support of NovaMedica. The most renowned experts in this medical field took to the stage to debate on strategies for combating migraines and on which medications should be the drugs of choice. It is indicative that supporters of both sides of the expert battle named the new products of NovaMedica Relonova^®[1] and Difendum^[1] indicated for the treatment of migraine-related headaches, as preferable.

• Expert says launch of Relonova in the Russian market has given doctors new options for treating migraines

  31 October 2023

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  On October 26-27, 2023, the First Russian Neurological Congress, one of the largest federal events for the medical community, took place in Moscow. At the congress, a report was presented by Elena FILATOVA (Doctor of Medical Sciences), Professor of the Department of Nervous System Diseases of the Institute of Professional Education of the Sechenov First Moscow State Medical University, on “New options for migraine therapy”, in which the speaker shared information on effective relief of migraine attacks – the possibilities of NSAID therapy and the new triptan in the Russian market, Relonova^®[1].

• New possibilities for combination therapy of sleep disorders discussed at the symposium held with the support of NovaMedica as part of the First Russian Neurological Congress

  27 October 2023

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  An interesting discussion of new possibilities and prospects in the treatment of insomnia took place at the symposium Combination Therapy of Sleep Disorders: Possibilities and Prospects organized with the support of NovaMedica within the framework of the First Russian Neurological Congress in Moscow. The urgent nature of this topic was evident – the hall was full! Participants – more than 100 representatives of the medical community – noted the valuable opportunity to gain fresh knowledge first-hand in a comprehensive manner from well-known specialists in somnology, neurology, psychiatry and clinical pharmacology. Among other things, NovaMedica’s new drug Levroso^® Long^[1] for the treatment of sleep disorders received high praise at the symposium.

• Experts in the treatment of headaches note the positive perception of new NovaMedica drugs by the medical community

  24 October 2023

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  At the 15^th anniversary applied research conference New Possibilities in Diagnostics and Treatment of Headaches in St. Petersburg, leading Russian experts noted the positive perception by the medical community of NovaMedica’s new products in the field of pain therapy – Relonova^®[1] and Difendum^®[1].